Weekend reads: Women in science, creative peer review, is civil discourse about science still possible?

booksAnother busy week at Retraction Watch. Here’s what was happening elsewhere: Continue reading Weekend reads: Women in science, creative peer review, is civil discourse about science still possible?

On vigorous scientific debates, witch hunts, and the tragedy of suicide

logoThe suicide earlier this week of Yoshiki Sasai, one of the scientists who worked on the now-discredited STAP stem cell work, was a startling and sobering reminder to the research community and the public that misconduct can take a heavy human toll – even on people like Sasai, whom by all accounts only had the misfortune of working with a dishonest colleague.

The tension surrounding this case and others was well-captured by University of California, Berkeley biologist Michael Eisen, who himself lost his father, also a scientist, to suicide in 1987 in a case that he said had haunting parallels to Sasai’s:

Obviously, fraud is a terrible thing. Nothing provides as deep an existential threat to the scientific enterprise than making up data. But as bad as it is, there is something deeply ugly about the way the scientific community responds to misconduct. We need to deal swiftly with fraud when it is identified. But time after time I have watched the way not only the accused, but everyone around them, is treated with such sanctimonious disdain it is frankly not surprising that some of them respond in tragic ways.

Some of the commenters on Eisen’s post, as well as here on Retraction Watch, have had questions like this: Continue reading On vigorous scientific debates, witch hunts, and the tragedy of suicide

STAP stem cell co-author commits suicide: Reports

Yoshiki Sasai, via RIKEN
Yoshiki Sasai, via RIKEN

In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.

According to the Japan Times, RIKEN deputy director Yoshiki Sasai has died: Continue reading STAP stem cell co-author commits suicide: Reports

Unearthed: The world’s first retraction

first retraction

 

A lovely birthday gift from reader Leonid Schneider, who also contributes cartoons to Lab Times, where we have a column.

Bonus: The world’s first art critic.

 

Happy fourth anniversary, Retraction Watch

logoYesterday was our fourth birthday. We published our first post, “Why write a blog about retractions?” on August 3, 2010, and the anniversary seems as good a time as any to review where we’ve been.

Here were some highlights of the past twelve months: Continue reading Happy fourth anniversary, Retraction Watch

Weekend reads: Dope-addicted doctors running drug trials; jailed for copyright violation?

booksAnother busy week at Retraction Watch. Here’s what was happening elsewhere:

Another Nature stem cell paper is retracted

nature 73014Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.

According to that 2010 news story:

The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.

But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Continue reading Another Nature stem cell paper is retracted

MD Anderson postdoc faked results of Novartis anti-cancer compound study

jun fu
Raymond Sawaya, director of MD Anderson’s brain tumor program, presents Jun Fu with the 2014 Caroline Ross Endowment Fellowship.

A former postdoc at MD Anderson Cancer Center faked the results of a mouse study of a Novartis compound designed to fight brain tumors, according to the Office of Research Integrity (ORI).

Jun Fu “admitted to knowingly and intentionally falsifying Figure 8a” in “Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor–Initiating Cells,” a paper published in Cancer Research on May 15, 2013:

Continue reading MD Anderson postdoc faked results of Novartis anti-cancer compound study

UT-Southwestern cancer research group notches ninth retraction

lung cancerA research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.

Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Continue reading UT-Southwestern cancer research group notches ninth retraction

Authors retract paper “confirming” that narcolepsy is an autoimmune disease

stmA group of researchers at Stanford and elsewhere is retracting a 2013 paper that another scientist told Nature was “one of the biggest things to happen in the narcolepsy field for some time.”

The Science Translational Medicine paper caused a buzz because it claimed to show that narcolepsy was an autoimmune disease. Here’s the notice: Continue reading Authors retract paper “confirming” that narcolepsy is an autoimmune disease